Detalhe da pesquisa
1.
Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial.
Lancet
; 403(10434): 1351-1361, 2024 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38490230
2.
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 73(3): 44, 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38349570
3.
The benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregivers.
Psychooncology
; 31(6): 1003-1012, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35083809
4.
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.
Cancer
; 127(11): 1779-1787, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33539547
5.
The role of human papillomavirus in nongenital cancers.
CA Cancer J Clin
; 63(1): 57-81, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23258613
6.
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients.
Curr Treat Options Oncol
; 21(12): 92, 2020 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33009956
7.
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
Cancer Immunol Immunother
; 67(5): 805-814, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29484464
8.
Window Studies in Squamous Cell Carcinoma of the Head and Neck: Values and Limits.
Curr Treat Options Oncol
; 19(12): 68, 2018 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30367283
9.
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).
Cancer Immunol Immunother
; 64(3): 367-79, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25537079
10.
Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients.
Oral Oncol
; 148: 106582, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38039877
11.
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Oral Oncol
; 149: 106634, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38118249
12.
Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.
Haematologica
; 98(4): 584-90, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23144192
13.
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
Nat Rev Cancer
; 23(3): 173-188, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36456755
14.
Quality of Life in Patients With Recurrent and Second Primary Head and Neck Cancer.
Otolaryngol Head Neck Surg
; 168(2): 196-202, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35316115
15.
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck.
Oral Oncol
; 140: 106363, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36963232
16.
American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma.
Head Neck
; 45(1): 32-41, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36181317
17.
Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic Cancers.
Curr Oncol
; 30(10): 8826-8840, 2023 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37887537
18.
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
Clin Cancer Res
; 29(4): 723-730, 2023 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36595540
19.
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 29(11): 2066-2074, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36806911
20.
Tumor cell p38 inhibition to overcome immunotherapy resistance.
Res Sq
; 2023 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37645831